Inflammatory breast cancer: vasculogenic mimicry and its hemodynamics of an inflammatory breast cancer xenograft model
about
Evading anti-angiogenic therapy: resistance to anti-angiogenic therapy in solid tumorsComparing vasculogenic mimicry with endothelial cell-lined vessels: techniques for 3D reconstruction and quantitative analysis of tissue components from archival paraffin blocks.Evaluation of the correlation of vasculogenic mimicry, ALDH1, KAI1 and microvessel density in the prediction of metastasis and prognosis in colorectal carcinoma.Number of glioma polyploid giant cancer cells (PGCCs) associated with vasculogenic mimicry formation and tumor grade in human glioma.Number of polyploid giant cancer cells and expression of EZH2 are associated with VM formation and tumor grade in human ovarian tumor.Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancerTumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer.Pixel-based absorption correction for dual-tracer fluorescence imaging of receptor binding potential.Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapyA pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro.IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer.A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cellsClaudin-4 is required for vasculogenic mimicry formation in human breast cancer cells.SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer.Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib.Nodal signaling promotes vasculogenic mimicry formation in breast cancer via the Smad2/3 pathway.Anti-angiogenic drug discovery: lessons from the past and thoughts for the future.Vasculogenic mimicry: a novel target for glioma therapy.Why is melanoma so metastatic?Melanoma vasculogenic mimicry capillary-like structure formation depends on integrin and calcium signaling.Tumor vasculogenic mimicry formation as an unfavorable prognostic indicator in patients with breast cancer.Overexpression of leptin receptor in human glioblastoma: Correlation with vasculogenic mimicry and poor prognosis.Inhibitory effects of B-cell lymphoma 2 on the vasculogenic mimicry of hypoxic human glioma cells.Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry.Doxycycline influences microcirculation patterns in B16 melanoma.Overview of advances in vasculogenic mimicry - a potential target for tumor therapy
P2860
Q26773795-C45427EF-1861-4E1F-BDC7-C8CA22C71901Q33286127-99B6F6C3-0206-4C31-8D51-4F79686671DBQ33588908-E1222EFA-41A7-41EC-8BEB-8F475F6FCC68Q33642824-C02212AB-AD29-43F3-8E36-08D18A031596Q33849806-29AC3439-4F37-40CF-84FA-A93D66D431F4Q33870504-C63C7C42-E28E-4E8F-932D-C135EBB4AD99Q34207659-F8F932C4-9C0F-4994-A06D-68AF3F041981Q34343963-62627779-D709-4218-8DE9-FDA34707B654Q34387497-479FF9C4-98B9-4860-B8E7-1C98B73751DCQ34391376-061A780F-2B5E-453C-8FBC-8EABE36ACCC4Q34995053-F6DC1189-AD0C-4BB8-A06A-B7720DAE7AE0Q35529018-7FF298DC-705F-4D0F-95F0-7B0B6A1CCA60Q35633657-B7C9A33D-330D-4EC8-B4AC-B3146B7D04D0Q35793725-74C48664-0E57-40DC-B3B6-AA0E0C1A6DB1Q37131869-CC9FCCBA-26E8-42DC-9F2F-8378F63FA13CQ37437544-352EABE8-C74C-4151-A6B2-20C48824DD47Q37688504-2C55B687-695A-4D1D-8EF3-8741E04421B7Q38020234-701F2482-5775-4B85-ABF1-22776F9BFF3DQ38118466-A04BB574-8DB8-4E92-BDDC-D3E01FB2A48EQ38150869-940AAAE2-3633-478F-BE36-DD216E04F6CEQ39570473-930B0235-1C29-4401-A768-342F5A8A6529Q41346466-A2058090-EAB2-4DBC-9A46-97493A3BA410Q41709352-B0B671E2-FA28-4513-BCE3-70B3497B715DQ41774881-12287395-8966-474C-A8E2-5EBA0971BF97Q51104351-E4DAAB2F-AE8F-4547-9A14-0BDC4C307FBBQ53520146-D7DF0B6D-6FB4-4B03-8BD3-6F01590E4D79Q58803491-6512BC78-64A6-4567-B34A-9CED61DC37B3
P2860
Inflammatory breast cancer: vasculogenic mimicry and its hemodynamics of an inflammatory breast cancer xenograft model
description
2003 nî lūn-bûn
@nan
2003 թուականին հրատարակուած գիտական յօդուած
@hyw
2003 թվականին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Inflammatory breast cancer: va ...... breast cancer xenograft model
@ast
Inflammatory breast cancer: va ...... breast cancer xenograft model
@en
Inflammatory breast cancer: va ...... breast cancer xenograft model
@nl
type
label
Inflammatory breast cancer: va ...... breast cancer xenograft model
@ast
Inflammatory breast cancer: va ...... breast cancer xenograft model
@en
Inflammatory breast cancer: va ...... breast cancer xenograft model
@nl
prefLabel
Inflammatory breast cancer: va ...... breast cancer xenograft model
@ast
Inflammatory breast cancer: va ...... breast cancer xenograft model
@en
Inflammatory breast cancer: va ...... breast cancer xenograft model
@nl
P2093
P2860
P921
P3181
P356
P1476
Inflammatory breast cancer: va ...... breast cancer xenograft model
@en
P2093
Atsushi Shimizu
Daijo Hashimoto
Hiro Wakasugi
Hisataka Kobayashi
Jun Sobajima
Kazuo Shirakawa
P2860
P2888
P3181
P356
10.1186/BCR585
P407
P577
2003-01-01T00:00:00Z
P5875
P6179
1025669954